Evidence map›Paper›PMID 40927277›Full record

ArticleBlood cell therapy2025

Late-onset immune thrombocytopenia after unrelated cord blood transplantation for chronic myelomonocytic leukemia.

Shoya Arai, Kensuke Matsumoto, Haruko Tashiro, Seiko Kato, Takaaki Konuma, Jun Ooi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cell therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shoya AraiDepartment of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan.
Kensuke MatsumotoDepartment of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan.
Haruko TashiroDepartment of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan.
Seiko KatoDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Takaaki KonumaDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Jun OoiDepartment of Transfusion Medicine and Cell-processing, Teikyo University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several reports have been published on autoimmune hematologic complications, including immune thrombocytopenia (ITP), after cord blood transplantation (CBT). However, there have been no reports of late-onset ITP following CBT. A 51-year-old male with chronic myelomonocytic leukemia received unrelated CBT in 2012. During regular follow-up visits every 3-6 months, his complete blood count remained normal until March 2024. In September 2024, 12 years after the CBT, the patient suddenly developed severe thrombocytopenia. Following a diagnosis of ITP, the patient was treated with intravenous immunoglobulins and prednisone. With follow-up period of 5 months after the onset of ITP, the patient is still alive with a platelet count of 126 × 10

Indexed as

allogeneic stem cell transplantationchronic myelomonocytic leukemiacord blood transplantationimmune thrombocytopenia

Identifiers

PMID40927277
PMCPMC12414648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.